{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:15:18Z","timestamp":1784873718317,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":2963,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1074\/mcp.m112.017483","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T20:31:50Z","timestamp":1335817910000},"page":"453-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Phosphoproteomic Analysis of Leukemia Cells under Basal and Drug-treated Conditions Identifies Markers of Kinase Pathway Activation and Mechanisms of Resistance"],"prefix":"10.1016","volume":"11","author":[{"given":"Maria P.","family":"Alcolea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Rodr\u00edguez-Prados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Vanhaesebroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro R.","family":"Cutillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M112.017483_bib1","doi-asserted-by":"crossref","first-page":"pe15","DOI":"10.1126\/scisignal.263pe15","article-title":"Challenges and opportunities in defining the essential cancer kinome","volume":"2","author":"Manning","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1074\/mcp.M112.017483_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1074\/mcp.M112.017483_bib3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1125951","article-title":"Targeting tyrosine kinases in cancer: The second wave","volume":"312","author":"Baselga","year":"2006","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1074\/mcp.M112.017483_bib4","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/annonc\/12.suppl_1.S35","article-title":"Mechanism of action of anti-HER2 monoclonal antibodies","volume":"12","author":"Baselga","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1074\/mcp.M112.017483_bib5","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1200\/JCO.2008.21.3264","article-title":"Targeting signal transducer and activator of transcription signaling pathway in leukemias","volume":"27","author":"Benekli","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1074\/mcp.M112.017483_bib6","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.ejca.2008.09.026","article-title":"Targeted therapies in breast cancer: Where are we now?","volume":"44","author":"Di Cosimo","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1074\/mcp.M112.017483_bib7","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S1471-4914(02)02305-5","article-title":"STI571 (Gleevec) as a paradigm for cancer therapy","volume":"8","author":"Druker","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1074\/mcp.M112.017483_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1074\/mcp.M112.017483_bib9","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1158\/0008-5472.CAN-06-4615","article-title":"Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases","volume":"67","author":"Raynaud","year":"2007","journal-title":"Cancer Res."},{"key":"10.1074\/mcp.M112.017483_bib10","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1200\/JCO.2004.01.185","article-title":"Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer","volume":"22","author":"Rinehart","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1074\/mcp.M112.017483_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/j.seminoncol.2008.04.004","article-title":"Deregulation of signaling pathways in acute myeloid leukemia","volume":"35","author":"Scholl","year":"2008","journal-title":"Semin. Oncol."},{"key":"10.1074\/mcp.M112.017483_bib12","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-08-1385","article-title":"NVP-BEZ235, a dual PI3K\/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations","volume":"68","author":"Serra","year":"2008","journal-title":"Cancer Res."},{"key":"10.1074\/mcp.M112.017483_bib13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1126\/science.1149200","article-title":"Cancer proliferation gene discovery through functional genomics","volume":"319","author":"Schlabach","year":"2008","journal-title":"Science"},{"key":"10.1074\/mcp.M112.017483_bib14","doi-asserted-by":"crossref","first-page":"16472","DOI":"10.1073\/pnas.0808019105","article-title":"Kinase requirements in human cells: I. Comparing kinase requirements across various cell types","volume":"105","author":"Grueneberg","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.M112.017483_bib15","doi-asserted-by":"crossref","first-page":"16490","DOI":"10.1073\/pnas.0806578105","article-title":"Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines","volume":"105","author":"Grueneberg","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.M112.017483_bib16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature06913","article-title":"The cancer biomarker problem","volume":"452","author":"Sawyers","year":"2008","journal-title":"Nature"},{"key":"10.1074\/mcp.M112.017483_bib17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","article-title":"The genomic landscapes of human breast and colorectal cancers","volume":"318","author":"Wood","year":"2007","journal-title":"Science"},{"key":"10.1074\/mcp.M112.017483_bib18","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1074\/mcp.M112.017483_bib19","doi-asserted-by":"crossref","first-page":"D652","DOI":"10.1093\/nar\/gkp995","article-title":"COSMIC (the Catalogue of Somatic Mutations in Cancer): A resource to investigate acquired mutations in human cancer","volume":"38","author":"Forbes","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1074\/mcp.M112.017483_bib20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"Greenman","year":"2007","journal-title":"Nature"},{"key":"10.1074\/mcp.M112.017483_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/446145a","article-title":"Cancer: Drivers and passengers","volume":"446","author":"Haber","year":"2007","journal-title":"Nature"},{"key":"10.1074\/mcp.M112.017483_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.1073096","article-title":"Cancer. Addiction to oncogenes: The Achilles heal of cancer","volume":"297","author":"Weinstein","year":"2002","journal-title":"Science"},{"key":"10.1074\/mcp.M112.017483_bib23","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1073\/pnas.0602101103","article-title":"Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase\/Akt signal transduction pathway by mass spectrometry","volume":"103","author":"Cutillas","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.M112.017483_bib24","series-title":"Proceedings of the 54th American Society for Mass Spectrometry Conference of Mass Spectrometry and Allied Topics","article-title":"Activitomics: Mulitiplex analysis of kinase activities by mass spectrometry","author":"Cutilllas","year":"2006"},{"key":"10.1074\/mcp.M112.017483_bib25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.1566","article-title":"Sensitive multiplexed analysis of kinase activities and activity-based kinase identification","volume":"27","author":"Kubota","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1074\/mcp.M112.017483_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/pmic.200800454","article-title":"Analytical strategies for phosphoproteomics","volume":"9","author":"Thingholm","year":"2009","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M112.017483_bib27","doi-asserted-by":"crossref","first-page":"12867","DOI":"10.1073\/pnas.0705158104","article-title":"Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma","volume":"104","author":"Huang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.M112.017483_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2006.09.026","article-title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks","volume":"127","author":"Olsen","year":"2006","journal-title":"Cell"},{"key":"10.1074\/mcp.M112.017483_bib29","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1073\/pnas.0608638104","article-title":"Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks","volume":"104","author":"Wolf-Yadlin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.M112.017483_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1073\/pnas.0409143102","article-title":"Quantitative phosphorylation profiling of the ERK\/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors","volume":"102","author":"Ballif","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/mcp.M112.017483_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2010.04.026","article-title":"Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors","volume":"17","author":"Carretero","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1074\/mcp.M112.017483_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/epr.11.14","article-title":"Phosphoproteomics of vasopressin signaling in the kidney","volume":"8","author":"Hoffert","year":"2011","journal-title":"Expert Rev. Proteomics"},{"key":"10.1074\/mcp.M112.017483_bib33","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","article-title":"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer","volume":"131","author":"Rikova","year":"2007","journal-title":"Cell"},{"key":"10.1074\/mcp.M112.017483_bib34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm1009-1158","article-title":"Shifting paradigms: The seeds of oncogene addiction","volume":"15","author":"Sawyers","year":"2009","journal-title":"Nat. Med."},{"key":"10.1074\/mcp.M112.017483_bib35","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/nm.2402","article-title":"Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanisms","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1074\/mcp.M112.017483_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nchembio.695","article-title":"A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer","volume":"7","author":"Muellner","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1074\/mcp.M112.017483_bib37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc2787","article-title":"Targeting the cancer kinome through polypharmacology","volume":"10","author":"Knight","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/mcp.M112.017483_bib38","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.003079","article-title":"A self-validating quantitative mass spectrometry method for assessing the accuracy of high-content phosphoproteomic experiments","author":"Casado","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M112.017483_bib39","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.003830","article-title":"Confident phosphorylation site localization using the Mascot Delta Score","author":"Savitski","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M112.017483_bib40","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1074\/mcp.M700037-MCP200","article-title":"Quantitative profile of five murine core proteomes using label-free functional proteomics","volume":"6","author":"Cutillas","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M112.017483_bib41","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1074\/mcp.M500078-MCP200","article-title":"Quantification of gel-separated proteins and their phosphorylation sites by LC-MS using unlabeled internal standards: Analysis of phosphoprotein dynamics in a B cell lymphoma cell line","volume":"4","author":"Cutillas","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M112.017483_bib42","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1074\/mcp.M800307-MCP200","article-title":"A new approach for quantitative phosphoproteomic dissection of signaling pathways applied to T cell receptor activation","volume":"8","author":"Nguyen","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M112.017483_bib43","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1021\/pr800619h","article-title":"Quantitative phosphoproteomics of tomato mounting a hypersensitive response reveals a swift suppression of photosynthetic activity and a differential role for hsp90 isoforms","volume":"8","author":"Stulemeijer","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1074\/mcp.M112.017483_bib44","doi-asserted-by":"crossref","first-page":"rs4","DOI":"10.1126\/scisignal.2001182","article-title":"Phosphoproteomic analysis reveals interconnected system-wide responses to perturbations of kinases and phosphatases in yeast","volume":"3","author":"Bodenmiller","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1074\/mcp.M112.017483_bib45","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/rcm.386","article-title":"Strategies for determination of insulin with tandem electrospray mass spectrometry: Implications for other analyte proteins?","volume":"15","author":"Fierens","year":"2001","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1074\/mcp.M112.017483_bib46","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.bmcl.2004.01.012","article-title":"Beyond U0126: Dianion chemistry leading to the rapid synthesis of a series of potent MEK inhibitors","volume":"14","author":"Wityak","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1074\/mcp.M112.017483_bib47","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1158\/0008-5472.CAN-05-4280","article-title":"Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells","volume":"66","author":"Pedranzini","year":"2006","journal-title":"Cancer Res."},{"key":"10.1074\/mcp.M112.017483_bib48","doi-asserted-by":"crossref","first-page":"15461","DOI":"10.1074\/jbc.C200665200","article-title":"The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif","volume":"278","author":"Nojima","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1074\/mcp.M112.017483_bib49","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.biocel.2003.11.008","article-title":"Signal transducer and activator of transcription 5 (STAT5)","volume":"36","author":"Buitenhuis","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1074\/mcp.M112.017483_bib50","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M600508200","article-title":"Independence of protein kinase C-delta activity from activation loop phosphorylation: Structural basis and altered functions in cells","volume":"281","author":"Liu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1074\/mcp.M112.017483_bib51","doi-asserted-by":"crossref","first-page":"15771","DOI":"10.1016\/S0021-9258(18)98476-0","article-title":"The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C","volume":"266","author":"Toullec","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1074\/mcp.M112.017483_bib52","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1016\/S0021-9258(18)98335-3","article-title":"Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976","volume":"268","author":"Martiny-Baron","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1074\/mcp.M112.017483_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ctrv.2010.07.004","article-title":"Use of molecular markers for predicting therapy response in cancer patients","volume":"37","author":"Duffy","year":"2011","journal-title":"Cancer Treat. Rev."},{"key":"10.1074\/mcp.M112.017483_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00439-011-0990-0","article-title":"Preclinical strategies to define predictive biomarkers for therapeutically relevant cancer subtypes","volume":"130","author":"Pajic","year":"2011","journal-title":"Hum. Genet."},{"key":"10.1074\/mcp.M112.017483_bib55","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/jcb.23090","article-title":"Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells","volume":"112","author":"Ruvolo","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1074\/mcp.M112.017483_bib56","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3109\/10428194.2011.572323","article-title":"Enhanced invasiveness in multidrug resistant leukemic cells is associated with overexpression of P-glycoprotein and cellular inhibitor of apoptosis protein","volume":"52","author":"Hu","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1074\/mcp.M112.017483_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1008073006495","article-title":"Protein kinases and multidrug resistance","volume":"27","author":"Rumsby","year":"1998","journal-title":"Cytotechnology"},{"key":"10.1074\/mcp.M112.017483_bib58","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of cancer therapy: Oncogene and non-oncogene addiction","volume":"136","author":"Luo","year":"2009","journal-title":"Cell"},{"key":"10.1074\/mcp.M112.017483_bib59","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/0008-5472.CAN-09-1577","article-title":"Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)","volume":"70","author":"Dry","year":"2010","journal-title":"Cancer Res."},{"key":"10.1074\/mcp.M112.017483_bib60","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/sj.onc.1209169","article-title":"RNAi-based screening of the human kinome identifies Akt-cooperating kinases: A new approach to designing efficacious multitargeted kinase inhibitors","volume":"25","author":"Morgan-Lappe","year":"2006","journal-title":"Oncogene"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620329911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620329911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M112.017483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:44:50Z","timestamp":1761525890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620329911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1535947620329911"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m112.017483","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphoproteomic Analysis of Leukemia Cells under Basal and Drug-treated Conditions Identifies Markers of Kinase Pathway Activation and Mechanisms of Resistance","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M112.017483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}